PUGLISI, FRANCESCO
 Distribuzione geografica
Continente #
EU - Europa 1
NA - Nord America 1
Totale 2
Nazione #
IT - Italia 1
US - Stati Uniti d'America 1
Totale 2
Città #
Ashburn 1
Milan 1
Totale 2
Nome #
Controversial topics in metastatic HR+/HER2- breast cancer: Guiding treatment by a modified Delphi approach 5
Impact of Hormone Receptor Status and Tumor Subtypes on Clinical Behavior and Outcomes of Breast Cancer in Young BRCA Carriers 4
Deciding on the best pharmacotherapy for advanced triple-negative breast cancer: expert guidance 1
Positioning of Tucatinib in the New Clinical Scenario of HER2-Positive Metastatic Breast Cancer: An Italian and Spanish Consensus Paper 1
The role of the molecular tumor board: learnings from the ROME trial 1
Optimizing choices and sequences in the diagnostic-therapeutic landscape of advanced triple-negative breast cancer: An Italian consensus paper and critical review 1
Corrigendum to “Optimizing choices and sequences in the diagnostic-therapeutic landscape of advanced triple-negative breast cancer: An Italian consensus paper and critical review” [Cancer Treatm. Rev. 114 (2023) 102511] (Cancer Treatment Reviews (2023) 114, (S0305737223000026), (10.1016/j.ctrv.2023.102511)) 1
Parp-inhibitors in the therapeutic landscape of breast cancer patients with BRCA1 and BRCA2 pathogenic germline variants: An Italian consensus paper and critical review 1
Trastuzumab deruxtecan in hormone receptor-positive, HER2-low/-ultralow metastatic breast cancer (DESTINY-Breast06): outcome analyses by time to progression on prior first-line endocrine therapy with CDK4/6 inhibitor and baseline burden of disease 1
News from the San Antonio Breast Cancer Symposium 2022 1
Totale 17
Categoria #
all - tutte 32
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2025/202617 0 0 0 0 0 0 0 0 0 0 2 15
Totale 17